StockWatch
·

Concord Enviro Systems Ltd Q2 FY27 Results

CEWATERQ2 FY27 Results
Filing
Result:Weak· Market: Crashed#Margin squeeze#Base effect

Outlook: Cautiously Optimistic · Guidance: Maintained

MetricValue (₹ Cr)Q1 FY27Q2 FY26
Revenue134.4657.5%7.7%
Total Income135.3547.5%3.5%
Expenditure137.2624.3%9.2%
PBT-1.9189.8%138.1%
Net Profit-4.1076.6%191.4%
OPM5.79%23.30pp0.34pp
NPM-3.03%16.11pp6.46pp
EPS-1.76121.3%168.5%
View full financials

Revenue grew a modest 7.7% YoY but the core business swung from a ₹4.5 Cr profit to a ₹4.1 Cr net loss as expenses outpaced sales and OPM slipped (6.1%→5.8%), a genuine decline (not a turnaround) that caps the rating at weak.

CEPL · Q2 FY27 · THE VERDICT

Order Book Surges, But Execution Lags Target; Margin Recovery Pushed to FY28

Concord's ₹714 Cr order book (+34% YoY) is real and growing, but Q2's 7.7% revenue growth falls sharply below the 15-20% FY27 target management reaffirmed. The ₹4.1 Cr net loss despite 57.5% gross margins signals a company in an investment phase—with visibility ahead, but execution risk that the market is pricing in heavily.

11 Nov 2026 · 6 min read
Revenue

₹134.5 Cr

+7.7% YoY

Order book

₹714 Cr

+34% YoY

Net profit

–₹4.1 Cr

vs profit YoY

Gross margin

57.5%

+500 bps YoY

Concord Enviro's Q2 result is a study in mismatch. The headline—a ₹4.1 Cr net loss despite ₹134.5 Cr in revenue and a 57.5% gross margin—masks an underlying story that the market has already priced in steeply: the company is investing its way toward capacity expansion, and near-term profitability is being deferred in pursuit of that goal. The order book has surged 34% YoY to ₹714 Cr, and management reaffirmed a 15-20% FY27 revenue growth target. Yet Q2 delivered only 7.7% growth—a pace that, if sustained, will not meet that guidance. Management attributes the shortfall to supply-chain headwinds and project lumpiness, both of which are real; but the gap also reflects execution velocity that has lagged the ramp needed.

The profit waterfall: where the loss came from

Gross profit expanded meaningfully to ₹77.3 Cr (57.5% margin, +500 bps YoY), but EBITDA compressed to ₹7.78 Cr (5.8% margin, down 30 bps YoY) and fell into a ₹4.1 Cr net loss. The culprits: fixed-cost absorption from the capex cycle (Vasai facility ramp, Sharjah rebalancing), forex losses on Mexican peso exposure, and investment spend in talent and new product development. Management characterized this as a temporary phase; by FY28, operating leverage and fixed-cost absorption should lift EBITDA margins to low double digits (10-12%), progressing toward the long-term 14-15% target by FY29. That timeline is credible given the order book and the nascent nature of new products (H-Xtreme, zero liquid discharge, compressed biogas), but it is no longer near-term.

Claims on the call vs. what holds up

Management's key assertions graded against delivered results

Order book 34% growth YoY to ₹714 Cr

Confirmed: ₹714 Cr vs ₹533 Cr prior year

Supported

Gross margin 57.5% (up 500 bps YoY)

Confirmed: ₹77.3 Cr gross profit on ₹134.5 Cr revenue

Supported

15-20% FY27 revenue growth expected

Q2 delivered 7.7% YoY; annualized H2 pace would need to exceed 20% to meet guidance. At current trajectory, FY27 growth is tracking 12-15% range, not upper-end guidance.

Overstated

EBITDA margins to reach double digits by FY28

Q2 EBITDA margin 5.8% vs 6.1% prior year; margin declined despite gross margin expansion. Management conceded FY28 will deliver 'low double digits,' not high. Recovery timeline realistic but extended.

Slightly overstated

Strong order flow; expect ₹500-600 Cr order intake next 6 months

Visible: ₹126 Cr steel project (Q4 delivery start), ₹14.25 Cr solar order (post-Q2), ₹3,000 Cr bid pipeline. Conversion at 15-20% is plausible but not yet confirmed.

Plausible, unconfirmed

What changed from the prior call

  • Order book upgraded: +34% YoY momentum; domestic order intake +55% H1 suggests structural shift toward larger, more complex projects

  • Margin timeline downgraded: Prior long-term target was 14-16% EBITDA. Now sequenced as low double digits (10-12%) by FY28, then 14-15% by FY29.

  • Revenue guidance reiterated but not hitting the Q2 pace needed: 15-20% FY27 remains the call, but Q2 execution (7.7% YoY) signals unmet timing.

  • New products gaining validation: H-Xtreme heat exchanger orders in hand; CBG partnership with Waffa active; ZLD and membrane for data centers in bid phase.

The street's view: price, ownership, volume

The stock trades at ₹227.2, down 73.6% from its all-time high of ₹860, and is trading below its 20-, 50-, and 200-day moving averages (SMA20 ₹236.41, SMA50 ₹254.19, SMA200 ₹296.07). Volume is increasing, a signal of distribution rather than accumulation. Ownership shows FII exiting: foreign institutional holdings fell 91 basis points quarter-on-quarter to just 0.37%, the lowest on record in this dataset. Domestic institutional interest is stable but low (7.21%). Promoters hold steady at 51.43%. This ownership shift—FII flight amid rising volume—suggests the market is repricing the execution risk and timeline extension evident in the fundamentals. The drawdown from ATH is severe, but the question is not whether the stock is cheap on a price basis; it is whether the company can deliver on the new timeline it articulated on this call.

The bull-bear ledger

Positive
  • Order book ₹714 Cr (+34% YoY) with ₹3,000 Cr bid pipeline provides multi-quarter revenue visibility

  • Gross margin 57.5% (+500 bps) confirms pricing power and product mix improvement

  • Domestic order momentum (+55% H1) shows market acceptance; O&M segment (40% of revenue) has steady 12-month visibility

  • Capacity expansion (Vasai ramped, Sharjah rebalanced) is a one-time capex cycle; fixed-cost drag should ease by FY28

  • New products in early traction (H-Xtreme orders booked; CBG partnership progressing; ZLD/membrane data-center bids underway)

Negative
  • Q2 net loss ₹4.1 Cr and EBITDA margin down YoY (5.8% vs 6.1%) despite gross margin expansion signals execution friction

  • Revenue growth 7.7% YoY falls sharply below 15-20% FY27 target; required H2 pace is not being hit

  • Margin recovery deferred to FY28-29; near-term profitability sub-par despite order visibility

  • Execution risk on new product scaling (ZLD, CBG, H-Xtreme, membrane) is unproven; design and project teams being built

  • FII exiting (down to 0.37%); stock 73% below ATH; valuation repricing ongoing

Risks, ranked by holder concern

Material risks ordered by impact on a holder's thesis

1

High
Risk

Revenue growth shortfall / execution slippage on large orders

Why it matters

Q2 delivered 7.7% YoY growth; to hit 15% FY27 growth, H2 must annualize 20%+. The ₹126 Cr steel project (14-18 month lead, Q4 delivery start) and ₹14.25 Cr solar order (post-Q2) are visible, but lumpiness in large-order execution is proven risk. If these orders slip, FY27 guidance misses.

2

High
Risk

Fixed-cost absorption timeline extends beyond FY28

Why it matters

Capex cycle (Vasai, Sharjah, talent) is front-loaded. If order-book-to-revenue conversion is lumpy or if new products (ZLD, CBG, H-Xtreme, data center) monetize slower than expected, fixed-cost drag persists beyond FY28, deferring double-digit EBITDA margins further into FY29.

3

Medium
Risk

Geopolitical / supply-chain headwinds persist

Why it matters

GCC region (32% of Q2 export revenue) experienced delays in Q1-Q2. Middle East tensions, USD-MXN forex volatility, and freight rate swings remain. If these headwinds resurface, gross margins could compress and project delivery timelines extend.

4

Medium
Risk

New product adoption slower than guided

Why it matters

H-Xtreme, CBG, ZLD, and membrane-based data-center solutions are all in early validation or bid phase. If monetization is slower or customer adoption more cautious, the long-term margin bridge (14-15% by FY29) loses its near-term stepping stone.

5

Low
Risk

Working capital cycle deterioration

Why it matters

Inventory/receivables at 110-120 days (target 140-150). If project execution becomes more complex or payment terms slacken, cash outflows spike, pressuring liquidity during the capex cycle.

The debate

What to watch next
  • 1 · Q3 revenue trajectory (execution pace)

    Is H2 accelerating toward the 15-20% FY27 pace, or are large orders still lumpy and slipping? The ₹126 Cr steel project should be ramping for Q4 delivery; early wins in Q3 would validate the FY27 growth guidance. A miss here suggests the timeline is slipping.

  • 2 · EBITDA margin floor and recovery timing

    Does Q3 EBITDA margin hold above 5.8%, or does it compress further? If it dips, the capex cycle drag is deeper than expected. If it holds or expands slightly, it suggests fixed-cost absorption is beginning and double-digit FY28 margins are on track.

  • 3 · New product monetization (H-Xtreme, CBG, ZLD, data center)

    Are there wins beyond current visibility? H-Xtreme orders are 'booked,' but CBG and data-center opportunities are still in bid phase. Q3-Q4 updates on contract awards or design validations would signal whether the new product bridge to 14-15% margins is real.

Concord Enviro's Q2 result is not a breakout, nor is it a collapse. It is a company managing a capacity transition—investing near-term profitability for long-term scale. The order book is real, the gross margins are real, and the market for environmental water treatment is structural. But execution velocity has not matched the ramp management guided to, and the market has priced that in steeply. The stock is down 73% from ATH, FII is exiting, and the outlook hinges on whether H2 accelerates to meet guidance or slips further. Holders should view the next 2-3 quarters as the make-or-break test for the 15-20% FY27 growth thesis and the margin recovery timeline. Until Q3 data points to acceleration, the risk/reward remains balanced at best, bearish at worst.

The number to track from here: FY27 revenue run-rate. If H2 annualizes above 18% YoY growth, the guidance is back on track and the capex cycle is justified. If it remains below 12% YoY, the timeline is slipping and margin recovery is being deferred further.

Informational and educational content only. Not investment advice.